- Home
- Publications
- Publication Search
- Publication Details
Title
Programmable nanoparticle functionalization for in vivo targeting
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 27, Issue 1, Pages 255-264
Publisher
FASEB
Online
2012-10-10
DOI
10.1096/fj.12-218081
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of STAT1 from Mouse Mammary Epithelium Results in an Increased Neu-Induced Tumor Burden
- (2015) Peter J. Klover et al. NEOPLASIA
- Development of a Magnetic Resonance Imaging Protocol for the Characterization of Atherosclerotic Plaque by Using Vascular Cell Adhesion Molecule-1 and Apoptosis-Targeted Ultrasmall Superparamagnetic Iron Oxide Derivatives
- (2012) Carmen Burtea et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation
- (2011) Jennifer F. Raven et al. CELL CYCLE
- Improved signal processing to detect cancer by ultrasonic molecular imaging of targeted nanoparticles
- (2011) Michael Hughes et al. JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
- Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling
- (2010) Hua Pan et al. BIOMATERIALS
- Methods for the Functionalisation of Nanoparticles: New Insights and Perspectives
- (2010) Thomas Perrier et al. CHEMISTRY-A EUROPEAN JOURNAL
- The Design of Multifunctional Microbubbles for Ultrasound Image-Guided Cancer Therapy
- (2010) Francesca Cavalieri et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures
- (2010) Hua Pan et al. FASEB JOURNAL
- Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms
- (2010) Thomas Perrier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Quantitative magnetic resonance fluorine imaging: today and tomorrow
- (2010) Junjie Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Multifuntional Nanoparticles: Preparation and Applications in Biomedicine and in Non-Invasive Bioimaging
- (2010) Andrea Masotti Recent Patents on Nanotechnology
- Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics
- (2009) Megan M. Kaneda et al. ANNALS OF BIOMEDICAL ENGINEERING
- Thermodynamics of Melittin Binding to Lipid Bilayers. Aggregation and Pore Formation†
- (2009) Gabriela Klocek et al. BIOCHEMISTRY
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- 18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis
- (2009) Matthias Nahrendorf et al. JACC-Cardiovascular Imaging
- In VivoTumor Cell Targeting with “Click” Nanoparticles
- (2008) Geoffrey von Maltzahn et al. BIOCONJUGATE CHEMISTRY
- Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting IκBα Kinase-NFκB
- (2008) Chen Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Detection of targeted perfluorocarbon nanoparticle binding using19F diffusion weighted MR spectroscopy
- (2008) Emily A. Waters et al. MAGNETIC RESONANCE IN MEDICINE
- Synthesis and Characterization of Stable Fluorocarbon Nanostructures as Drug Delivery Vehicles for Cytolytic Peptides
- (2008) Neelesh R. Soman et al. NANO LETTERS
- Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells
- (2007) Dong-Oh Moon et al. TOXICON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now